Loading…
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study
PI-QUAL (Prostate Imaging Quality) is a new score used to standardize the assessment of multiparametric magnetic resonance imaging (mpMRI). We provide further evidence that PI-QUAL has clinical implications. mpMRI of insufficient quality, defined as PI-QUAL
Saved in:
Published in: | European urology open science (Online) 2023-01, Vol.47, p.94-101 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c525t-711828d703a98536af4991058e3082b27bdadc5f25811ee8bb2f4495ddfbd9f13 |
---|---|
cites | cdi_FETCH-LOGICAL-c525t-711828d703a98536af4991058e3082b27bdadc5f25811ee8bb2f4495ddfbd9f13 |
container_end_page | 101 |
container_issue | |
container_start_page | 94 |
container_title | European urology open science (Online) |
container_volume | 47 |
creator | Windisch, Olivier Benamran, Daniel Dariane, Charles Favre, Martina Martins Djouhri, Mehdi Chevalier, Maxime Guillaume, Bénédicte Oderda, Marco Gatti, Marco Faletti, Riccardo Colinet, Valentin Lefebvre, Yolene Bodard, Sylvain Diamand, Romain Fiard, Gaelle |
description | PI-QUAL (Prostate Imaging Quality) is a new score used to standardize the assessment of multiparametric magnetic resonance imaging (mpMRI). We provide further evidence that PI-QUAL has clinical implications. mpMRI of insufficient quality, defined as PI-QUAL |
doi_str_mv | 10.1016/j.euros.2022.11.013 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9806708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S266616832202701X</els_id><sourcerecordid>2761180480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-711828d703a98536af4991058e3082b27bdadc5f25811ee8bb2f4495ddfbd9f13</originalsourceid><addsrcrecordid>eNp9kdFu0zAUhiMEYtPYEyAhX3KTYDuN4yCBVE0bVOpE19Fry7GPU1dpXGxnUt-LB8RrtzJuuLLl8___OT5flr0nuCCYsE-bAkbvQkExpQUhBSblq-ycMsZywnj5-sX9LLsMYYMxphUhrKZvs7OSMUzwhJ9nv5euB-QMimtAi5QYZQQ028rODh26G2Vv4x4tZvndajpH98p5QMb5v9Jb2Q0QrUJLCG6Qgzq64eS1A1rIuHa966ySPVrtkvGQPjURPFpKfXh_TlTRbfef0RTdjn3KhSGmltfpszuQA7qPo96_y94Y2Qe4fDovstXN9c-r7_n8x7fZ1XSeq4pWMa8J4ZTrGpey4VXJpJk0DcEVhxJz2tK61VKrytCKEwLA25aayaSptDatbgwpL7Kvx9zd2G5BH2aRvdh5u5V-L5y04t_KYNeicw-i4ZjVmKeAj08B3v0aIUSxtUFB38sB3BgErVmaMYHASVoepSrtIXgwpzYEi0fkYiMOyMUjckGISMiT68PLCU-eZ8BJ8OUogLSnBwteBGUhUdLWp1UL7ex_G_wBIrDB1w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2761180480</pqid></control><display><type>article</type><title>Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Windisch, Olivier ; Benamran, Daniel ; Dariane, Charles ; Favre, Martina Martins ; Djouhri, Mehdi ; Chevalier, Maxime ; Guillaume, Bénédicte ; Oderda, Marco ; Gatti, Marco ; Faletti, Riccardo ; Colinet, Valentin ; Lefebvre, Yolene ; Bodard, Sylvain ; Diamand, Romain ; Fiard, Gaelle</creator><creatorcontrib>Windisch, Olivier ; Benamran, Daniel ; Dariane, Charles ; Favre, Martina Martins ; Djouhri, Mehdi ; Chevalier, Maxime ; Guillaume, Bénédicte ; Oderda, Marco ; Gatti, Marco ; Faletti, Riccardo ; Colinet, Valentin ; Lefebvre, Yolene ; Bodard, Sylvain ; Diamand, Romain ; Fiard, Gaelle</creatorcontrib><description><![CDATA[PI-QUAL (Prostate Imaging Quality) is a new score used to standardize the assessment of multiparametric magnetic resonance imaging (mpMRI). We provide further evidence that PI-QUAL has clinical implications. mpMRI of insufficient quality, defined as PI-QUAL <3, results in a higher rate of pathological upstaging.
Increasing use of multiparametric magnetic resonance imaging (mpMRI) has come with heterogeneity in image quality. The Prostate Imaging Quality (PI-QUAL) score is under scrutiny to assess its usefulness in predicting clinical outcomes.
To compare upstaging of localized disease on mpMRI (mrT2) to locally invasive disease in radical prostatectomy (RP) specimens (≥pT3a) in relation to PI-QUAL.
Patients treated with RP between 2015 and 2020 who underwent 1.5–3-T mpMRI within 6 mo before surgery and had systematic and mpMRI-US targeted biopsies were included. mpMRI scans were retrospectively assigned a PI-QUAL score, and prospectively acquired Prostate Imaging-Recording and Data System (PI-RADS) scores (version 2.0 or 2.1) were used. PI-QUAL scores were categorized as nondiagnostic (PI-QUAL <3), sufficient (PI-QUAL 3), or optimal (PI-QUAL >3).
We assessed the relationship between the PI-QUAL score and upstaging using multivariate logistic regression. mpMRI, clinical, and pathological findings were compared using χ2 tests and analysis of variance.
We identified 351 patients, of whom 40 (11.4%) had PI-QUAL <3, 57 (16.3%) had PI-QUAL 3, and 254 (72.3%) had PI-QUAL >3 scores. The distribution of PI-QUAL <3 (0–33.6%; p < 0.001) and PI-QUAL >3 (37.3–100%; p < 0.001) scores varied widely among centers. PI-QUAL ≥3 in comparison to PI-QUAL <3 was associated with a lower rate of upstaging (19% vs 35%; p = 0.02), greater detection of mrT3a and mrT3b prostate cancer (17.0% vs 2.5%; p = 0.016), a higher rate of PI-RADS 5 lesions (47% vs 27.5%; p = 0.002), a higher number of suspicious lesion (PI-RADS ≥3: 34.7% vs 15%; p = 0.012), and higher detection rates for aggregated (50.7% vs 22.5%; p = 0.001) and late (21.2% vs 0%; p < 0.001) extraprostatic extension. On multivariate analysis, PI-QUAL<3 was associated with more frequent upstaging in the RP specimen (odds ratio 3.4; p = 0.01).
In comparison to PI-QUAL ≥3, PI-QUAL <3 was significantly associated with a higher rate of upstaging from organ-confined disease on mpMRI to locally advanced disease on pathology, lower detection rates for PI-RADS 5 lesions and extraprostatic extension, and a lower number of suspicious lesions.
Poor image quality for magnetic resonance imaging (MRI) scans of the prostate is associated with underestimation of the stage of prostate cancer.]]></description><identifier>ISSN: 2666-1683</identifier><identifier>ISSN: 2666-1691</identifier><identifier>EISSN: 2666-1683</identifier><identifier>DOI: 10.1016/j.euros.2022.11.013</identifier><identifier>PMID: 36601048</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Prostate Cancer</subject><ispartof>European urology open science (Online), 2023-01, Vol.47, p.94-101</ispartof><rights>2022 The Authors</rights><rights>2022 The Authors.</rights><rights>2022 The Authors 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-711828d703a98536af4991058e3082b27bdadc5f25811ee8bb2f4495ddfbd9f13</citedby><cites>FETCH-LOGICAL-c525t-711828d703a98536af4991058e3082b27bdadc5f25811ee8bb2f4495ddfbd9f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806708/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S266616832202701X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3547,27922,27923,45778,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36601048$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Windisch, Olivier</creatorcontrib><creatorcontrib>Benamran, Daniel</creatorcontrib><creatorcontrib>Dariane, Charles</creatorcontrib><creatorcontrib>Favre, Martina Martins</creatorcontrib><creatorcontrib>Djouhri, Mehdi</creatorcontrib><creatorcontrib>Chevalier, Maxime</creatorcontrib><creatorcontrib>Guillaume, Bénédicte</creatorcontrib><creatorcontrib>Oderda, Marco</creatorcontrib><creatorcontrib>Gatti, Marco</creatorcontrib><creatorcontrib>Faletti, Riccardo</creatorcontrib><creatorcontrib>Colinet, Valentin</creatorcontrib><creatorcontrib>Lefebvre, Yolene</creatorcontrib><creatorcontrib>Bodard, Sylvain</creatorcontrib><creatorcontrib>Diamand, Romain</creatorcontrib><creatorcontrib>Fiard, Gaelle</creatorcontrib><title>Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study</title><title>European urology open science (Online)</title><addtitle>Eur Urol Open Sci</addtitle><description><![CDATA[PI-QUAL (Prostate Imaging Quality) is a new score used to standardize the assessment of multiparametric magnetic resonance imaging (mpMRI). We provide further evidence that PI-QUAL has clinical implications. mpMRI of insufficient quality, defined as PI-QUAL <3, results in a higher rate of pathological upstaging.
Increasing use of multiparametric magnetic resonance imaging (mpMRI) has come with heterogeneity in image quality. The Prostate Imaging Quality (PI-QUAL) score is under scrutiny to assess its usefulness in predicting clinical outcomes.
To compare upstaging of localized disease on mpMRI (mrT2) to locally invasive disease in radical prostatectomy (RP) specimens (≥pT3a) in relation to PI-QUAL.
Patients treated with RP between 2015 and 2020 who underwent 1.5–3-T mpMRI within 6 mo before surgery and had systematic and mpMRI-US targeted biopsies were included. mpMRI scans were retrospectively assigned a PI-QUAL score, and prospectively acquired Prostate Imaging-Recording and Data System (PI-RADS) scores (version 2.0 or 2.1) were used. PI-QUAL scores were categorized as nondiagnostic (PI-QUAL <3), sufficient (PI-QUAL 3), or optimal (PI-QUAL >3).
We assessed the relationship between the PI-QUAL score and upstaging using multivariate logistic regression. mpMRI, clinical, and pathological findings were compared using χ2 tests and analysis of variance.
We identified 351 patients, of whom 40 (11.4%) had PI-QUAL <3, 57 (16.3%) had PI-QUAL 3, and 254 (72.3%) had PI-QUAL >3 scores. The distribution of PI-QUAL <3 (0–33.6%; p < 0.001) and PI-QUAL >3 (37.3–100%; p < 0.001) scores varied widely among centers. PI-QUAL ≥3 in comparison to PI-QUAL <3 was associated with a lower rate of upstaging (19% vs 35%; p = 0.02), greater detection of mrT3a and mrT3b prostate cancer (17.0% vs 2.5%; p = 0.016), a higher rate of PI-RADS 5 lesions (47% vs 27.5%; p = 0.002), a higher number of suspicious lesion (PI-RADS ≥3: 34.7% vs 15%; p = 0.012), and higher detection rates for aggregated (50.7% vs 22.5%; p = 0.001) and late (21.2% vs 0%; p < 0.001) extraprostatic extension. On multivariate analysis, PI-QUAL<3 was associated with more frequent upstaging in the RP specimen (odds ratio 3.4; p = 0.01).
In comparison to PI-QUAL ≥3, PI-QUAL <3 was significantly associated with a higher rate of upstaging from organ-confined disease on mpMRI to locally advanced disease on pathology, lower detection rates for PI-RADS 5 lesions and extraprostatic extension, and a lower number of suspicious lesions.
Poor image quality for magnetic resonance imaging (MRI) scans of the prostate is associated with underestimation of the stage of prostate cancer.]]></description><subject>Prostate Cancer</subject><issn>2666-1683</issn><issn>2666-1691</issn><issn>2666-1683</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kdFu0zAUhiMEYtPYEyAhX3KTYDuN4yCBVE0bVOpE19Fry7GPU1dpXGxnUt-LB8RrtzJuuLLl8___OT5flr0nuCCYsE-bAkbvQkExpQUhBSblq-ycMsZywnj5-sX9LLsMYYMxphUhrKZvs7OSMUzwhJ9nv5euB-QMimtAi5QYZQQ028rODh26G2Vv4x4tZvndajpH98p5QMb5v9Jb2Q0QrUJLCG6Qgzq64eS1A1rIuHa966ySPVrtkvGQPjURPFpKfXh_TlTRbfef0RTdjn3KhSGmltfpszuQA7qPo96_y94Y2Qe4fDovstXN9c-r7_n8x7fZ1XSeq4pWMa8J4ZTrGpey4VXJpJk0DcEVhxJz2tK61VKrytCKEwLA25aayaSptDatbgwpL7Kvx9zd2G5BH2aRvdh5u5V-L5y04t_KYNeicw-i4ZjVmKeAj08B3v0aIUSxtUFB38sB3BgErVmaMYHASVoepSrtIXgwpzYEi0fkYiMOyMUjckGISMiT68PLCU-eZ8BJ8OUogLSnBwteBGUhUdLWp1UL7ex_G_wBIrDB1w</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Windisch, Olivier</creator><creator>Benamran, Daniel</creator><creator>Dariane, Charles</creator><creator>Favre, Martina Martins</creator><creator>Djouhri, Mehdi</creator><creator>Chevalier, Maxime</creator><creator>Guillaume, Bénédicte</creator><creator>Oderda, Marco</creator><creator>Gatti, Marco</creator><creator>Faletti, Riccardo</creator><creator>Colinet, Valentin</creator><creator>Lefebvre, Yolene</creator><creator>Bodard, Sylvain</creator><creator>Diamand, Romain</creator><creator>Fiard, Gaelle</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230101</creationdate><title>Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study</title><author>Windisch, Olivier ; Benamran, Daniel ; Dariane, Charles ; Favre, Martina Martins ; Djouhri, Mehdi ; Chevalier, Maxime ; Guillaume, Bénédicte ; Oderda, Marco ; Gatti, Marco ; Faletti, Riccardo ; Colinet, Valentin ; Lefebvre, Yolene ; Bodard, Sylvain ; Diamand, Romain ; Fiard, Gaelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-711828d703a98536af4991058e3082b27bdadc5f25811ee8bb2f4495ddfbd9f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Prostate Cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Windisch, Olivier</creatorcontrib><creatorcontrib>Benamran, Daniel</creatorcontrib><creatorcontrib>Dariane, Charles</creatorcontrib><creatorcontrib>Favre, Martina Martins</creatorcontrib><creatorcontrib>Djouhri, Mehdi</creatorcontrib><creatorcontrib>Chevalier, Maxime</creatorcontrib><creatorcontrib>Guillaume, Bénédicte</creatorcontrib><creatorcontrib>Oderda, Marco</creatorcontrib><creatorcontrib>Gatti, Marco</creatorcontrib><creatorcontrib>Faletti, Riccardo</creatorcontrib><creatorcontrib>Colinet, Valentin</creatorcontrib><creatorcontrib>Lefebvre, Yolene</creatorcontrib><creatorcontrib>Bodard, Sylvain</creatorcontrib><creatorcontrib>Diamand, Romain</creatorcontrib><creatorcontrib>Fiard, Gaelle</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European urology open science (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Windisch, Olivier</au><au>Benamran, Daniel</au><au>Dariane, Charles</au><au>Favre, Martina Martins</au><au>Djouhri, Mehdi</au><au>Chevalier, Maxime</au><au>Guillaume, Bénédicte</au><au>Oderda, Marco</au><au>Gatti, Marco</au><au>Faletti, Riccardo</au><au>Colinet, Valentin</au><au>Lefebvre, Yolene</au><au>Bodard, Sylvain</au><au>Diamand, Romain</au><au>Fiard, Gaelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study</atitle><jtitle>European urology open science (Online)</jtitle><addtitle>Eur Urol Open Sci</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>47</volume><spage>94</spage><epage>101</epage><pages>94-101</pages><issn>2666-1683</issn><issn>2666-1691</issn><eissn>2666-1683</eissn><abstract><![CDATA[PI-QUAL (Prostate Imaging Quality) is a new score used to standardize the assessment of multiparametric magnetic resonance imaging (mpMRI). We provide further evidence that PI-QUAL has clinical implications. mpMRI of insufficient quality, defined as PI-QUAL <3, results in a higher rate of pathological upstaging.
Increasing use of multiparametric magnetic resonance imaging (mpMRI) has come with heterogeneity in image quality. The Prostate Imaging Quality (PI-QUAL) score is under scrutiny to assess its usefulness in predicting clinical outcomes.
To compare upstaging of localized disease on mpMRI (mrT2) to locally invasive disease in radical prostatectomy (RP) specimens (≥pT3a) in relation to PI-QUAL.
Patients treated with RP between 2015 and 2020 who underwent 1.5–3-T mpMRI within 6 mo before surgery and had systematic and mpMRI-US targeted biopsies were included. mpMRI scans were retrospectively assigned a PI-QUAL score, and prospectively acquired Prostate Imaging-Recording and Data System (PI-RADS) scores (version 2.0 or 2.1) were used. PI-QUAL scores were categorized as nondiagnostic (PI-QUAL <3), sufficient (PI-QUAL 3), or optimal (PI-QUAL >3).
We assessed the relationship between the PI-QUAL score and upstaging using multivariate logistic regression. mpMRI, clinical, and pathological findings were compared using χ2 tests and analysis of variance.
We identified 351 patients, of whom 40 (11.4%) had PI-QUAL <3, 57 (16.3%) had PI-QUAL 3, and 254 (72.3%) had PI-QUAL >3 scores. The distribution of PI-QUAL <3 (0–33.6%; p < 0.001) and PI-QUAL >3 (37.3–100%; p < 0.001) scores varied widely among centers. PI-QUAL ≥3 in comparison to PI-QUAL <3 was associated with a lower rate of upstaging (19% vs 35%; p = 0.02), greater detection of mrT3a and mrT3b prostate cancer (17.0% vs 2.5%; p = 0.016), a higher rate of PI-RADS 5 lesions (47% vs 27.5%; p = 0.002), a higher number of suspicious lesion (PI-RADS ≥3: 34.7% vs 15%; p = 0.012), and higher detection rates for aggregated (50.7% vs 22.5%; p = 0.001) and late (21.2% vs 0%; p < 0.001) extraprostatic extension. On multivariate analysis, PI-QUAL<3 was associated with more frequent upstaging in the RP specimen (odds ratio 3.4; p = 0.01).
In comparison to PI-QUAL ≥3, PI-QUAL <3 was significantly associated with a higher rate of upstaging from organ-confined disease on mpMRI to locally advanced disease on pathology, lower detection rates for PI-RADS 5 lesions and extraprostatic extension, and a lower number of suspicious lesions.
Poor image quality for magnetic resonance imaging (MRI) scans of the prostate is associated with underestimation of the stage of prostate cancer.]]></abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36601048</pmid><doi>10.1016/j.euros.2022.11.013</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2666-1683 |
ispartof | European urology open science (Online), 2023-01, Vol.47, p.94-101 |
issn | 2666-1683 2666-1691 2666-1683 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9806708 |
source | ScienceDirect Journals; PubMed Central |
subjects | Prostate Cancer |
title | Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A38%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20the%20Prostate%20Imaging%20Quality%20PI-QUAL%20Score%20for%20Prostate%20Magnetic%20Resonance%20Image%20Quality%20in%20Pathological%20Upstaging%20After%20Radical%20Prostatectomy:%20A%20Multicentre%20European%20Study&rft.jtitle=European%20urology%20open%20science%20(Online)&rft.au=Windisch,%20Olivier&rft.date=2023-01-01&rft.volume=47&rft.spage=94&rft.epage=101&rft.pages=94-101&rft.issn=2666-1683&rft.eissn=2666-1683&rft_id=info:doi/10.1016/j.euros.2022.11.013&rft_dat=%3Cproquest_pubme%3E2761180480%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c525t-711828d703a98536af4991058e3082b27bdadc5f25811ee8bb2f4495ddfbd9f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2761180480&rft_id=info:pmid/36601048&rfr_iscdi=true |